(Q43830952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

chronic lymphocytic leukemia

1 reference

A Olsson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Diaz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Aguilar-Santelises

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Osterborg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Celsing

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Jondal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

L M Osorio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

1868-1877

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753607%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402287

5 December 2019

exact match

0 references

cites work

The kiss of death: promises and failures of death receptors and ligands in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

The role of c-FLIP in modulation of CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

IAP family proteins--suppressors of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

The cellular biology of B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

What does apoptosis mean in CLL?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Guidelines for protocol studies in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Expression of TRAIL and its receptors in human brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

The complexity of TNF-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021

Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402287

7 January 2021